Back to search

Article

The efficacy of first-line ART regimens based on RPV in HIV-infected patients with pre-existing E138A mutation in reverse transcriptase

2021-04-09

Abstract excerpt

<h4>Introduction: </h4> It was previously shown that the presence of the E138A mutation is associated with resistance to rilpivirine (RPV). Detection of this mutation is considered as contraindication for RPV use within the first-line ART. It is a lack of knowledge regarding efficacy of first-line RPV-based ART in patients bearing HIV with E138A mutation. In absence of HIV genotyping in naïve patients it may influ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61c27f13-bcd2-52db-b970-7eae053e3a5c
DOI
10.21203/rs.3.rs-402978/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The efficacy of first-line ART regimens based on RPV in HIV-infected patients with pre-existing E138A mutation in reverse transcriptaseDOI 10.21203/rs.3.rs-402978/v1
Select a neighboring publication to make it the new centre.